End stage and chronic kidney disease: Associations with renal cancer

Frontiers in Oncology

Volumn 2, Issue APR, 2012, Pages

  Russo, Paul ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Chronic kidney disease; Kidney cancer; Partial nephrectomy; Radical nephrectomy; Renal insufficiency

Indexed keywords

CREATININE; UREMIC TOXIN;

AGING; CANCER CONTROL; CANCER MORTALITY; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONSERVATIVE TREATMENT; DIALYSIS; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY CANCER; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; NEPHRECTOMY; PARTIAL NEPHRECTOMY; PREVALENCE; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR;

EID: 84877617914     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2012.00028     Document Type: Review

References (66)

1. Algaba, F., Akaza, H., López-Beltrán, A., Martignoni, G., Moch, H., Montironi, R., and Reuter, V. (2011). Current pathology keys of renal cell carcinoma. Eur. Urol. 60, 634-643.
2. Bijol, V., Mendez, G. P., Hurwitz, S., Rennke, H. G., and Nosé, V. (2006). Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure. Am. J. Surg. Pathol. 30, 575.
3. Birkelan, S. A., Lokkegaard, H., and Storm, H. H. (2000). Cancer risk in patients on dialysis and after renal transplantation. Lancet 355, 1886-1887.
4. Bonsib, S. M., and Pei, Y. (2010). The non-neoplastic kidney in tumor nephrectomy specimens: what can it show and what is important? Adv. Anat. Pathol. 4, 235-250.
5. Buell, J. F., Gross, T. G., and Woodle, E. S. (2005). Malignancy after transplantation. Transplantation 80, S254-S264.
6. Campbell, S. C., Novick, A. C., Belldegrun, A., Blute, M. L., Chow, G. K., Derweesh, I. H., Faraday, M. M., Kaouk, J. H., Leveille, R. J., Matin, S. F., Russo, P., and Uzzo, R. G. (2009). Guideline for management of the clinical T1 renal mass. J. Urol. 182, 1271-1279.
7. Cengiz, K. (2002). Increased incidence of neoplasia in chronic renal failure (20 year experience). Int. Urol. Nephrol. 33, 121-126.
8. Chobanian, A. V., Bakris, G. L., Black, H. R., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., Roccella, E. J., and the National High Blood Pressure Education Program Coordinating Committee. (2003). The Seventh Report of the Joint National Committee on TN prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289, 2560-2572.
9. Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., and Levey, A. S. (2007). Prevalence of chronic kidney disease in the United States. JAMA 298, 2038-2047.
10. Dou, L., Cerini, C., Brunet, P., Guillanelli, C., Moal, V., Grau, G., De Smet, R., Vanholder, R., Sampol, J., and Berland, Y. (2002). P-cresol, a uremic toxin, decreases endothelial cell response to inflammatory cytokines. Kidney Int. 62, 1999-2009.
11. Dulabon, L. M., Lowrance, W. T., Russo, P., and Huang, W. C. (2010). Trends in renal tumor surgery delivery within the United States. Cancer 116, 2316-2321.
12. Faure, V., Cerini, C., Paul, P., Berland, Y., Dignat-George, F., and Brunet, P. (2006). The uremic solute p-cresol decreases leukocyte transendothelial migration in vitro. Int. Immunol. 10, 1453-1459.
13. Fehrman-Ekholm, I., Duner, F., Brink, B., Tydén, G., and Elinder, C. G. (2001). No evidence of accelerated loss of kidney function in living kidney donors: results from a cross sectional follow up. Transplantation 72, 444-449.
14. Foley, R. N., Wang, C., and Collins, A. J. (2005). Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES 3 study. Mayo Clin. Proc. 80, 1270-1277.
15. Foyil, K. V., Ames, C. D., Ferguson, Weld, K. J., Figenshau, R. S., Venkatesh, R., Yan, Y., Clayman, R. V., and Landman, J. (2008). Long-term changes in creatinine clearance after laparoscopic renal surgery. J. Am. Coll. Surg. 206, 511-515.
16. Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., and Hsu, C. Y. (2004). Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Eng. J. Med. 351, 1296.
17. Goh, A., and Vathsala, A. (2011). Re: native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients. Am. J. Transplant. 11, 86-92.
18. Goldfarb, D. A., Matin, S. F., Braun, W. E., Schreiber, M. J., Mastroianni, B., Papajcik, D., Rolin, H. A., Flechner, S., Goormastic, M., and Novick, A. C. (2001). Renal outcome 25 years after donor nephrectomy. J. Urol. 166, 2043.
19. Hajj, P., Ferlicot, S., Massoud, W., Awad, A., Hammoudi, Y., Carpentier, B., Durrbach, A., Droupy, S., and Benoit, G. (2009). Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure. Urology 74, 631-634.
20. Henriksen, K. J., Meehan, S. M., and Chang, A. (2009). Nonneoplastic kidney diseases in adult tumor nephrectomy and nephroureterectomy specimens: common, harmful, yet underappreciated. Arch. Pathol. Lab. Med. 133, 1012-1025.
21. Hollenback, B. K., Tash, D. A., Miller, D. C., Dunn, R. L., and Wei, J. T. (2006). National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology 67, 254-259.
22. Hora, M., Hes, O., Reischig, T., Urge, T., Klecka, J., Ferda, J., Michal, M., and Eret, V. (2008). Tumors in end-stage kidney. Transplant. Proc. 10, 3354-3358.
23. Huang, W. C., Elkin, E. B., Levey, A. S., Jang, T. L., and Russo, P. (2009). Partial nephrectomy versus radical nephrectomy in patients with small renal tumors-is there a difference in mortality and cardiovascular outcomes. J. Urol. 181, 55-62.
24. Huang, W. C., Levey, A. S., Serio, A. M., Snyder, M., Vickers, A. J., Raj, G. V., Scardino, P. T., and Russo, P. (2006). Chronic kidney disease after nephrectomy in patients with renal cortical tumors: a retrospective cohort study. Lancet Oncol. 7, 735-740.
25. Ishikawa, I., and Kovacs, G. (1993). High incidence of papillary renal cell tumors in patients on chronic haemodialysis. Histopathology 22, 135-139.
26. Kaplan, C., Pasternack, B., Shah, H., and Gallo, G. (1975). Age-related incidence of sclerotic glomeruli in human kidneys. Am. J. Pathol. 80, 227.
27. Kattan, M. W., Reuter, V., Motzer, R. J., Katz, J., and Russo, P. (2001). A postoperative prognostic nomogram for renal cell. J. Urol. 166, 63-67.
28. Kidney Disease Outcome Quality Initiative. (2002). K/DOQI clinical guideline for chronic kidney disease evaluation, classification, stratification. Am. J. Kidney Dis. 39 (Suppl. 2), 51:5246.
29. Lane, B. R., Poggio, E. D., Herts, B. R., Novick, A. C., and Campbell, S. C. (2009). Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care. J. Urol. 182, 436-444.
30. Lau, W. K., Blute, M. L., Weaver, A. L., Torres, V. E., and Zincke, H. (2000). Matched comparison of radical nephrectomy vs. nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contra lateral kidney. Mayo Clin. Proc. 75, 1236-1242.
31. Launay-Vacker, V., Oudard, S., Janus, N., Gligorov, J., Pourrat, X., Rixe, O., Morere, J. F., Beuzeboc, P., Deray, G., and Renal Insufficiency and Cancer Medications (IRMA) Study Group. (2007). Prevalence of renal insufficiency in cancer patients and implications for anti cancer drug management. The renal insufficiency and anticancer medications study (IRMA). Cancer 110, 1376-1384.
32. Lee, J. E., Han, S. H., Cho, B. C., Park, J. T., Yoo, T. H., Kim, B. S., Park, H. C., Kang, S. W., Lee, H. Y., Han, D. S., Ha, S. K., and Choi, K. H. (2009). Cancer in patients on chronic dialysis. J. Korean Med. Sci. 24 (Suppl. 1), S95-S101.
33. Liang, J. A., Sun, L. M., Yeh, J. J., Sung, F. C., Chang, S. N., and Kao, C. H. (2011). The association between malignancy and end stage renal disease in Taiwan. Jpn. J. Clin. Oncol. 41, 752-757.
34. Lipworth, L., McLaughlin, J. K., Tarone, R. E., and Blot, W. J. (2011). Renal cancer paradox: higher incidence but not higher mortality among African-Americans. Eur. J. Cancer Prev. 20, 331-333.
35. Ljungberg, B., Campbell, S. C., Cho, H. Y., Jacqmin, D., Lee, J. E., Weikert, S., and Kiemeney, L. A. (2011). The epidemiology of renal cell carcinoma. Eur. Urol. 60, 615-621.
36. Lowrance, W. T., Yee, D. S., Savage, C., Cronin, A. M., O'Brien, M. F., Donat, M., Vickers, A., and Russo, P. (2010). Complications after radical and partial nephrectomy as a function of age. J. Urol. 183, 1725-1730.
37. Mandayam, S., and Shahinian, V. B. (2008). Are chronic dialysis patients at increased risk for cancer? J. Nephrol. 21, 166-174.
38. Matas, A. J., Simmons, R. L., Kjellstrand, C. M., Buselmeier, T. J., and Naajarian, J. S. (1975). Increased incidence of malignancy during chronic renal failure. Lancet 1, 883-886.
39. McKiernan, J., Simmons, R., Katz, J., and Russo, P. (2002). Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 59, 816-820.
40. McLaughlin, J. K., and Lipworth, L. (2000). Epidemiologic aspects of renal cell cancer. Semin. Oncol. 27, 115-123.
41. Miller, D. C., Hollingsworth, J. M., Hafez, K. S., Daignault, S., and Hollenbeck, B. K. (2006a). Partial nephrectomy for small renal masses. An emerging quality of care concern? J. Urol. 175, 853-857.
42. Miller, D. C., Taub, D. A., Dunn, R. L., Wei, J. T., and Hollenbeck, B. K. (2006b). Laparoscopy for renal cell carcinoma: diffusion versus regionalization? J. Urol. 176, 1102-1106.
43. Mosconi, G., Stalterii, L., Centofanti, F., Capelli, I., Carretta, E., Persici, E., Ubaldi, G., Battaglino, G., Raimondi, C., Scolari, M. P., and Stefoni, S. (2011). Incidence o cancer in kidney transplantation waiting list patients: a single center experience. Transplant. Proc. 43, 1003-1005.
44. Neuzillett, Y., Mathieu, R., Long, J. A., Gigante, M., Paparel, P., Poissonnier, L., Baumert, H., Escudier, B., Lang, H., Rioux-Leclercq, N., Bigot, P., Bernhard, J. C., Albiges, L., Bastien, L., Petit, J., Saint, F., Bruyere, F., Boutin, J. M., Brichart, N., Karam, G., Branchereau, J., Ferriere, J. M., Wallerand, H., Barbet, S., Elkentaoui, H., Hubert, J., Feuillu, B., Theveniaud, P. E., Villers, A., Zini, L., Descazeaux, A., Roupret, M., Barrou, B., Fehri, K., Lebret, T., Tostain, J., Terrier, J. E., Terrier, N., Martin, L., Dugardin, F., Galliot, I., Staerman, F., Azemar, M. D., Irani, J., Tisserand, B., Timsit, M. O., Sallusto, F., Rischmann, P., Guy, L., Valeri, A., Deruelle, C., Azzouzi, A. R., Chautard, D., Mejean, A., Salomon, L., Rigaud, J., Pfister, C., Soulié, M., Kleinclauss, F., Badet, L., Patard, J. J., and Comité de Transplantation de l'Association Française d'Urologie, and Comité de Cancérologie de l'Association Française d'Urologie. (2011). Renal cell carcinoma (RCC) in patients with end stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Eur. Urol. 60, 366-373.
45. Nouth, M. A., Kuroda, N., Yamashita, M., Hayashida, Y., Yano, T., Minakuchi, J., Taniguchi, S., Nomura, I., Inui, M., Sugimoto, M., and Kakehi, Y. (2009). Renal cell carcinoma in patients with end stage renal disease: relationship between histological type and duration of dialysis. BJU Int. 105, 620-627.
46. Nuttail, M., Cathcart, van der Meulen, J., Gillatt, D., McIntosh, G., and Emberton, M. (2005). A description of radical nephrectomy practice and outcomes in England: 1995-2002. BJU Int. 96, 58-61.
47. Ritz, E., and McClellan, W. W. (2004). Overview: increased cardiovascular risk in patients with minor renal dysfunction: an emerging issue with far-reaching consequences. J. Am. Soc. Nephrol. 15, 513-516.
48. Russo, P. (2000). Renal cell carcinoma: presentation, staging, and surgical treatment. Semin. Oncol. 27, 160-176.
49. Russo, P. (2006). "Open radical nephrectomy for localized renal cell carcinoma," in Genitourinary Oncology, 3rd Edn, ed. N. J. Vogelzang (Philadelphia: Lippincott Williams and Wilkins), 725-731.
50. Russo, P. (2010). Partial nephrectomy for renal cancer (I). BJU Int. 105, 1206-1220.
51. Russo, P. (2011). The role of surgery in the management of early-stage renal cancer. Hematol. Oncol. Clin. North Am. 25, 737-752.
52. Russo, P., Jang, T., Eggener, S., Pettus, J., Karellas, M., and O'Brien, F. (2008). Survival rates after resection for localized kidney cancer 1989-2004. Cancer 113, 84-96.
53. Sarnak, M., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., Parfrey, P., Pfeffer, M., Raij, L., Spinosa, D. J., and Wilson, P. W. (2003). Kidney disease as a risk factor for the development of cardiovascular disease: a statement from the American Heart Association Council on Kidney in Cardiovascular Disease. High blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 108, 2154-2169.
54. Segev, D. L., Muzaale, A. D., Caffo, B. S., Mehta, S. H., Singer, A. L., Taranto, S. E., McBride, M. A., and Montgomery, R. A. (2010). Perioperative mortality and long-term survival following live kidney donation. JAMA 503, 959-966.
55. Shlipak, M. G., Fried, L. F., Cushman, M., Manolio, T. A., Peterson, D., Stehman-Breen, C., Bleyer, A., Newman, A., Siscovick, D., and Psaty, B. (2005). Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 293, 1737-1745.
56. Stengel, B. (2010). Chronic kidney disease and cancer: a troubling connection. J. Nephrol. 23, 253-262.
57. Stenvinkel, P. (2010). Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. J. Int. Med. 268, 456-467.
58. Stevens, L. A., Coresh, J., Green, T., and Levey, A. S. (2006). Assessing kidney function-measured and estimated glomerular filtration rate. N. Engl. J. Med. 354, 2473-2483.
59. Stevens, L. A., Li, S., Wang, C., Becker, B. N., Bomback, A. S., Brown, W. W., Burrows, N. R., Jurkovitz, C. T., McFarlane, S. I., Norris, K. C., Shilpak, M., Whaley-Cornell, A. T., Chen, S. C., Barkis, G. L., and McCullough, P. A. (2010). Prevalence of CKD and co morbid illness in elderly patients in the United State: results from the Kidney Early Evaluation Program (KEEP). Am. J. Kidney Dis. 55 (3 Suppl. 2), S23-S33.
60. Stewart, J. H., Vajdoc, C. M., van Leeuwen, M. T., Amin, J., Webster, A. C., Chapman, J. R., McDonald, S. P., Grulich, A. E., and McCredie, M. R. (2009). The pattern of excess cancer in dialysis and transplantation. Nephrol. Dial. Transplant. 10, 3225-3231.
61. Suson, K. D., Sausville, J. E., Sener, A., and Phelan, M. W. (2011). Native nephrectomy for renal cell carcinoma in transplant recipients. Transplantation 91, 1376-1379.
62. Teloken, P. E., Thompson, R. H., Tickoo, S. K., Cronin, A., Savage, C., Reuter, V. E., and Russo, P. (2009). Prognostic impact of histological subtype in patients with surgically treated localized renal cell carcinoma. J. Urol. 182, 2132-2136.
63. Thompson, H. R., Boorjian, S. A., Lohse, C. M., Leibovich, B. C., Kwon, E. D., Cheville, J. C., and Blute, M. L. (2008). Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared to partial nephrectomy. J. Urol. 179, 468-473.
64. Thompson, H. R., Kaag, M., Vickers, a., Kundu, S., Bernstein, M., Lowrance, W., Galvin, D., Dalbagni, G., Touijer, K., and Russo, P. (2009). Contemporary use of partial nephrectomy nephrectomy at a tertiary care center in the United States. J. Urol. 181, 993-997.
65. Weng, P. H., Hung, K. Y., Huang, H. L., Chen, J. H., Sung, P. K., and Huang, K. C. (2011). Cancer specific mortality in chronic kidney disease: longitudinal follow up of a large cohort. Clin. J. Am. Soc. Nephrol. 6, 1121-1128.
66. Wong, G., Hayen, A., Chapman, J. R., Webster, A. C., Want, J. J., Mitchell, P., and Craig, J. C. (2009). Association of CKD and cancer risk in older people. J. Am. Soc. Nephrol. 20, 1341-1350.